The earlier bowel cancer is picked up, the easier it is to treat successfully.
Bowel cancer is the fourth most common cancer in the UK and the second most common cause of cancer death.
44 people die from the disease every day in the UK, which is equivalent to four entire football teams. But the great news is that if detected at the earliest stage, more than nine out of ten people with bowel cancer will survive the disease for more than five years.
So if you do spot any unusual changes to your body, tell your doctor. In most cases it won't be cancer - but if it is, finding it early can make a real difference.
Small changes make a difference
Bowel cancer research
Bowel cancer research projects funded by the Bobby Moore Fund include:
Professor Daniel Longley at Queen’s University, Belfast is exploring whether immunotherapies – treatments that harness the power of our immune system to fight cancer – could be used to treat advanced bowel cancer, in patients for whom chemotherapy is not effective. He is building on earlier research, funded by BMF, to delve deeper into the genetics of patients’ tumours, to determine whether those who don’t respond to chemotherapy might benefit from an immunotherapy.
Professor Eva Morris at the University of Leeds is developing CORECT-R, short for the UK COloRECTal cancer Repository, a huge collection of data from patients with bowel cancer from across the UK. Not only does she aim to rectify differences in survival for bowel cancer patients from different backgrounds across the UK, she also hopes to link up clinical trials within the dataset, to find out whether certain types of bowel cancer respond better to certain treatments.